An interventional study of high intensity dysphagia therapy in Dysphagia Following Cerebrovascular Accident, sponsored by Johns Hopkins University. Completed at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Johns Hopkins University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 230 studies in Deglutition Disorders with a site in United States — 43 open to participants now, 48 under way, none of them phase 3. Deglutition Disorders · United States.
Among the 230 studies in Deglutition Disorders with a site in United States, this one is the 122nd largest by enrollment of the 165 interventional ones that give a count, is one of 6 that started in 2023, is one of 118 with no phase, and was the 192nd registered.
875 studies on the registry are indexed under Deglutition Disorders; 237 are open to participants now.
Browse Deglutition Disorders studies →43 of the 230 studies in Deglutition Disorders with a site in United States are open now. Recruiting first, the newest first:
National Institute of Allergy and Infectious Diseases (NIAID) · Sites in United States, Mali
Ages 18–65
Medical University of South Carolina · Sites in United States
Ages up to 6 mo
Johns Hopkins University · Sites in United States
Ages 5–21
Nova Southeastern University · Sites in United States
Ages 18–99
Vanessa Torrecillas · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 137 Deglutition Disorders studies recruiting now, 75 (55%) set no upper age limit and 26 (19%) stop at 75 or younger; 15 take children under 18; 20 take healthy volunteers.
This study: 18 Years to 99 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
230 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 29 · Phase 3 12 · Phase 4 5
First in 1979; this study’s year is marked. 6 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 19 is below the median of 60 across 581 interventional studies indexed under Deglutition Disorders.
Median enrollment 50 across the 165 interventional studies, 62 across the 64 observational. Of the 156 that completed or were terminated, 54 (35%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 230 have an industry lead sponsor. The 10 most frequent:
Johns Hopkins University is the lead sponsor of 1,817 studies on the registry; 316 are open to participants now.
Of its 208 completed or terminated interventional studies of FDA-regulated products, 144 (69%) have results posted.
Johns Hopkins University has 4 studies filed under Deglutition Disorders — fewer than ten, so there is no comparison to draw.
21 of the studies in Deglutition Disorders with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05497219University Health Network, TorontoReference Values for Videofluoroscopic Measures of Swallowing | 2026-11-30 |
| NCT06670521University of Colorado, DenverCorticosteroids for Post-Extubation Dysphagia | 2026-11-30 |
| NCT05603897University of MiamiNon-standardized vs. Standardized Screening for Dysphagia | 2026-11-30 |
| NCT02838316Peter Belafsky, MDAutologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia | 2026-12 |
| NCT04074356Vanderbilt University Medical CenterNon-invasive Markers of Esophageal Function in Adults | 2026-12-30 |
Add all 21 to your calendar (.ics) → With an account.
Among the 230 studies in Deglutition Disorders with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to determine a standardized protocol for swallowing therapy and this protocol's effects on recovery after a stroke
This study will include adults, aged 18-99, who are admitted to Johns Hopkins Bayview (JHBMC) Rehabilitation Unit following an acute ischemic stroke with a diagnosis of dysphagia, determined by instrumental assessment with a Video Fluoroscopic Swallowing Study (VFSS). All participants will be asked to complete an informed consent form prior to admission to the study. Initial objective assessment of swallowing with video fluoroscopic swallowing assessment will be completed within 72 hours of admission to the unit. Participants with PAS scores of greater than or equal to 3 and FOIS scores of less than or equal to 6 will be admitted to the study and asked to complete the Eating Assessment Tool (EAT-10) score sheets. Intensive swallowing interventions with Speech Language Pathologists will begin within 24 hours. Daily treatment will include two 30-minute sessions, 5-6 days a week which will include the evidence-based dysphagia exercises focusing on tongue resistance, head lift/chin tuck against resistance and expiratory muscle strength training tasks. Devices utilized will include the Iowa Oral Performance Instrument (IOPI), and the Positive Expiratory Pressure (PEP) Respironics device or the Expiratory Muscle Strength Training (EMST150) device. Each session will involve IOPI measurements of lingual strength with endurance tasks set at 60% and 75% max strength scores to be completed for total of 10 attempts at each level for isometric and isokinetic tasks; Expiratory muscle strength training with EMST150 or PEP Respironics (dependent on strength levels) will be set at 75% max resistance levels per training method, for 25 completions per session; Shaker or Chin Tuck Against Resistance (CTAR) using 4.5 inch standard rubber ball - determined by patient positioning restrictions or tolerance- will be completed with goals of isometric hold for 1 minute x3 attempts and isokinetic x10 x3 attempts each session. At least one session per day will include consumption of ice chips and/or food dependent on PAS levels. At least one additional VFSS will be completed prior to discharge from study, as is standard of care within the JHBMC Rehab Unit. Outcome measures will be assessed with pre and post PAS scores (comparing initial and final VFSS results), EAT 10 scores and FOIS scores as well as documented improvements in IOPI and EMST/PEP levels at two-week intervals and will continue throughout the acute comprehensive inpatient rehabilitation unit (ACIR) stay as indicated. A follow up phone call with each participant will occur between 4-6 weeks post discharge from the and be completed with EAT-10 and FOIS over phone by Speech Language Pathologists or the investigator.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants with acute dysphagia who will receive high intensity dysphagia therapy during stay in inpatient rehab facility
Other: high intensity dysphagia therapy
Intensive swallowing interventions with Speech Language Pathologists to begin within 24 hours of video swallow study results. Daily treatment will include two 30-minute sessions, 5-6 days a week which will include the evidence-based dysphagia exercises focusing on tongue resistance, head lift/chin tuck against resistance and expiratory muscle strength training tasks
Number of participants with improved swallowing as assessed by the improved Penetration Aspiration Scale (PAS)
Measured with improved Penetration Aspiration Scale (PAS)
Time frame: up to 6 weeks
Number of participants with improved swallowing as assessed by the Functional Oral Intake Scale (FOIS)
Measured with the Functional Oral Intake Scale (FOIS)
Time frame: up to 6 weeks
Number of participants with perceived improvements in swallowing
Measured with improved EAT-10 Questionnaire Scores
Time frame: up to 6 weeks
Plan to share: No
Ran from Nov 2023 to primary completion in Nov 2026, 35 months.
Of 290 non-industry interventional studies with no phase under Deglutition Disorders, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's 35 months is above that.
Counting every sponsor, half of 299 studies reached it within 21 months; a quarter within 10 and three quarters within 38.
Completion moved once since we started tracking on Sep 25, 2026: Nov 2027 → Nov 2026, on Nov 12, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.